Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.
about
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standardsThe emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applicationsMyeloid-Derived Suppressor Cells in Bacterial InfectionsTumor-Associated Macrophages and Neutrophils in Tumor MicroenvironmentNeutrophils in Cancer: Two Sides of the Same CoinPaving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the FateHDAC inhibitors and immunotherapy; a double edged sword?Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationshipMyeloid-derived suppressor cells as therapeutic target in hematological malignanciesRegulatory dendritic cells in the tumor immunoenvironmentSunitinib: the antiangiogenic effects and beyondMonitoring of the Immune Dysfunction in Cancer PatientsSignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyMyeloid-derived cells are key targets of tumor immunotherapyThe Nature of Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentThe emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironmentIdentification of myeloid derived suppressor cells in dogs with naturally occurring cancerMesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia PatientsHepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.Interface of signal transduction inhibition and immunotherapy in melanoma.Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.Very small size proteoliposomes abrogate cross-presentation of tumor antigens by myeloid-derived suppressor cells and induce their differentiation to dendritic cellsTargeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.Tumor regression is mediated via the induction of HER263-71- specific CD8+ CTL activity in a 4T1.2/HER2 tumor model: no involvement of CD80 in tumor control.Immunological deregulation in classic hodgkin lymphoma.Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression.Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression.CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancerTumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesTumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism.Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophilsBuilding on sipuleucel-T for immunologic treatment of castration-resistant prostate cancer.Targeting CD8+ T-cell tolerance for cancer immunotherapy.Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resectionPeripheral blood MDSCs, IL-10 and IL-12 in children with asthma and their importance in asthma development.Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumorsMyeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.Intralesional delivery of dendritic cells engineered to express T-bet promotes protective type 1 immunity and the normalization of the tumor microenvironment.
P2860
Q26744395-96653724-CD3E-4A4A-8F4A-3DF8E1635529Q26747516-C132F31A-3E7F-4BF6-A785-213A192C9B6BQ26749373-B9B47B3D-6F21-4739-88D2-92F87A4E3542Q26766429-B555B046-5FCA-4A89-8118-53693D565E25Q26773072-39FA203F-2FE9-4232-AE9E-FCB66A07CF70Q26777205-F738CC18-313A-46CB-850B-08D838ADB0B8Q26853102-6F5D5041-3930-4609-83CC-4C969BD0F0DEQ27000087-04A126FF-F8E8-42BE-95BF-1D120539991EQ27010234-43599F4D-D228-40BB-8E09-5AA0881ACBF7Q27023084-5EA8F5CB-9D8B-493E-AF9F-116302DB06C0Q28066499-829D4AE0-5B83-4D73-BCC2-D12BA6C57743Q28072712-7740D4EE-575F-4B65-B272-0DED3652CDF9Q28080262-463E08B5-F471-42DE-AE3E-CEE921F86760Q28388246-9A4293AA-A1DA-4051-80CE-5D7D31B38651Q28388630-9DE947AB-4DD5-4003-9390-BF82BFB68F9CQ28396481-45FE665B-7B28-4DBE-AC01-2FF7B08AE57FQ28481476-94103F63-E3E2-4CD2-8CEE-F612165DF291Q28552532-12036311-EA2B-406A-B639-C27C520A35C0Q30277650-D066F643-0CC3-4A3D-A536-2231261D171DQ30415763-9CBA1CC8-85D1-4619-ABE8-B601FEC2B0D2Q30429380-355D7579-372A-49F9-ADC8-83CDA6D94824Q33606107-B0C0972F-5FAF-491F-BD03-3143D7E24F5CQ33606156-83DDC39C-13DC-4EAF-A04D-29CBAC10D394Q33609699-387245F1-3C46-4C3C-AF21-B8D02DD9EBB0Q33678308-18FD442E-A2D7-44E4-93EA-478E9008E09FQ33688821-9D563B21-693A-4C19-8A13-898DD784F9FDQ33778391-464764F1-1935-40B9-A7C2-B59D6A33278EQ33854515-7565BC3E-1BAF-4291-8E66-C16EBC45F449Q33903025-6BCFFDAC-6FF5-43C7-9BAE-EE559A0CCC24Q34043804-9512419B-735E-4FB9-9EB7-231D121D873FQ34044797-C60BF7A2-4ACE-4428-B148-E1CFE0025FF0Q34081723-E176ED6C-409D-418C-B2EC-2F57895B6533Q34163579-B40588B1-DC5C-4DA4-BDCB-E86E3D524672Q34321844-3E8F42DF-679E-4153-9B3F-6FC46748485EQ34432692-2EFDAA31-2C34-4437-AD03-5575523DA29CQ34625208-FD3DC0A7-C357-48A3-B1A0-B6250AC3AB0EQ34744569-EA4D910C-F0F1-44B9-BD47-95FE4A0DE2EFQ35073253-31D00116-57D5-4B05-81E9-B2D1EBC9A090Q35141469-A3193939-053F-4DC8-B14E-6C5B356C14C0Q35152154-BB7E7AE3-BD4F-4FE2-85AA-2C14149EE833
P2860
Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.
@ast
Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.
@en
type
label
Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.
@ast
Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.
@en
prefLabel
Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.
@ast
Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.
@en
P2093
P2860
P356
P1476
Mechanism of T cell tolerance induced by myeloid-derived suppressor cells
@en
P2093
Dmitry I Gabrilovich
Esteban Celis
Hyun-Il Cho
Srinivas Nagaraj
P2860
P304
P356
10.4049/JIMMUNOL.0902661
P407
P577
2010-02-08T00:00:00Z